Dentsply International (XRAY) Scheduled to Post Quarterly Earnings on Tuesday

Share on StockTwits

Dentsply International (NASDAQ:XRAY) is scheduled to be announcing its earnings results on Tuesday, February 18th. Investors that wish to register for the company’s conference call can do so using this link.

Dentsply International (NASDAQ:XRAY) opened at 46.24 on Monday. Dentsply International has a 52 week low of $39.90 and a 52 week high of $50.99. The stock’s 50-day moving average is $47.10 and its 200-day moving average is $45.62. The company has a market cap of $6.596 billion and a P/E ratio of 18.19.

A number of analysts have recently weighed in on XRAY shares. Analysts at Ned Davis Research downgraded shares of Dentsply International from a “buy” rating to a “neutral” rating in a research note on Monday, February 10th. On the ratings front, analysts at Credit Suisse upgraded shares of Dentsply International from a “neutral” rating to an “outperform” rating in a research note on Wednesday, December 11th. Finally, analysts at Goldman Sachs upgraded shares of Dentsply International from a “neutral” rating to a “buy” rating in a research note on Wednesday, December 11th. They now have a $56.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $47.67.

DENTSPLY International Inc (NASDAQ:XRAY) is a designer, developer, manufacturer and marketer of a range of dental products.

Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Union Pacific Receives “Strong-Buy” Rating from Raymond James
Union Pacific Receives “Strong-Buy” Rating from Raymond James
Tesco PLC Given “Underperform” Rating at Sanford C. Bernstein
Tesco PLC Given “Underperform” Rating at Sanford C. Bernstein
TCF Financial PT Raised to $19.00
TCF Financial PT Raised to $19.00
Entergy  Scheduled to Post Quarterly Earnings on Tuesday
Entergy Scheduled to Post Quarterly Earnings on Tuesday
GlaxoSmithKline plc Lowered to Underperform at Mainfirst
GlaxoSmithKline plc Lowered to Underperform at Mainfirst
La Jolla Pharmaceutical Company Stock Price Up 5.6% on Insider Buying Activity
La Jolla Pharmaceutical Company Stock Price Up 5.6% on Insider Buying Activity


Leave a Reply

 
© 2006-2014 Mideast Time.